A strong body of research indicates that cancer-associated fibroblasts (CAFs) and inflammatory factors in the TME, such as interleukin 6 (IL-6) and interferon-g (IFN-g), macrophages, and T cell-dependent immune responses, affected tumor growth through the HH signaling pathway (Zhang et al. 2021). This evidence concerns the gene IL6 and cancer.